CVS Health (NYSE:CVS) Stock Price Expected to Rise, Mizuho Analyst Says

CVS Health (NYSE:CVS) had its target price raised by analysts at Mizuho from $88.00 to $95.00 in a research report issued to clients and investors on Wednesday, Marketbeat reports. The brokerage currently has an “outperform” rating on the pharmacy operator’s stock. Mizuho’s price objective would suggest a potential upside of 20.19% from the stock’s previous close.

Other analysts have also recently issued research reports about the company. Wells Fargo & Company reduced their price target on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. The Goldman Sachs Group assumed coverage on CVS Health in a report on Tuesday, October 14th. They issued a “buy” rating and a $91.00 target price for the company. Sanford C. Bernstein increased their price target on CVS Health from $77.00 to $86.00 and gave the company a “market perform” rating in a report on Thursday, December 4th. Truist Financial set a $100.00 price objective on shares of CVS Health in a research note on Wednesday. Finally, Raymond James Financial upped their price objective on shares of CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $93.24.

CVS Health Stock Up 1.0%

CVS stock opened at $79.04 on Wednesday. The company has a 50 day moving average of $78.82 and a two-hundred day moving average of $71.59. The company has a market cap of $100.34 billion, a price-to-earnings ratio of 207.92, a PEG ratio of 0.75 and a beta of 0.48. CVS Health has a 12-month low of $43.56 and a 12-month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts anticipate that CVS Health will post 5.89 earnings per share for the current fiscal year.

Institutional Investors Weigh In On CVS Health

A number of institutional investors have recently added to or reduced their stakes in CVS. Severin Investments LLC increased its stake in CVS Health by 124.9% during the third quarter. Severin Investments LLC now owns 14,789 shares of the pharmacy operator’s stock valued at $1,115,000 after acquiring an additional 8,212 shares during the period. Allworth Financial LP grew its holdings in shares of CVS Health by 7.2% during the 3rd quarter. Allworth Financial LP now owns 28,764 shares of the pharmacy operator’s stock worth $2,169,000 after purchasing an additional 1,922 shares in the last quarter. IFP Advisors Inc increased its position in shares of CVS Health by 5.6% during the third quarter. IFP Advisors Inc now owns 25,463 shares of the pharmacy operator’s stock valued at $1,920,000 after purchasing an additional 1,345 shares during the period. Steadtrust LLC raised its stake in shares of CVS Health by 1.8% in the third quarter. Steadtrust LLC now owns 10,175 shares of the pharmacy operator’s stock valued at $767,000 after purchasing an additional 175 shares in the last quarter. Finally, CIBC Bancorp USA Inc. bought a new position in CVS Health in the third quarter worth $13,183,000. 80.66% of the stock is owned by institutional investors and hedge funds.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.